Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Haidar JN"'
Autor:
Poole A; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Karuppiah V; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Hartt A; School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, USA., Haidar JN; Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Moureau S; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Dobrzycki T; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Hayes C; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Rowley C; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Dias J; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Harper S; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Barnbrook K; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Hock M; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Coles C; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Yang W; Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Aleksic M; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Lin AB; Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Robinson R; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Dukes JD; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Liddy N; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Van der Kamp M; School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, BS8 1TD, USA., Plowman GD; Eli Lilly & Co, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Vuidepot A; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Cole DK; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA., Whale AD; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA. andrew.whale@immunocore.com., Chillakuri C; Immunocore Ltd., 92 Park Drive, Milton Park, Abingdon, OX14 4RY, USA. chandramouli.chillakuri@immunocore.com.
Publikováno v:
Nature communications [Nat Commun] 2022 Sep 10; Vol. 13 (1), pp. 5333. Date of Electronic Publication: 2022 Sep 10.
Autor:
Kotanides H; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. helen.kotanides@lilly.com mkalos@arsenalbio.com., Li Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Malabunga M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Carpenito C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Eastman SW; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Shen Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Wang G; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Inigo I; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Surguladze D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Pennello AL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Persaud K; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Hindi S; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Topper M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chen X; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Zhang Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Bulaon DK; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Bailey T; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Lao Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Han B; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Torgerson S; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chin D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sonyi A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Haidar JN; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Novosiadly RD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Moxham CM; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Plowman GD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Ludwig DL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. helen.kotanides@lilly.com mkalos@arsenalbio.com.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Oct; Vol. 8 (10), pp. 1300-1310. Date of Electronic Publication: 2020 Jul 27.
Autor:
Kotanides H; Lilly Research Laboratories, Eli Lilly and Company, New York, New York. helen.kotanides@lilly.com., Sattler RM; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Lebron MB; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Carpenito C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Shen J; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Li J; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Surguladze D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Haidar JN; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Burns C; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Shen L; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Inigo I; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Pennello AL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Forest A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chen X; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Chin D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sonyi A; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Topper M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Boucher L; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Sharma P; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Zhang Y; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Burtrum D; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Novosiadly RD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Ludwig DL; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Plowman GD; Lilly Research Laboratories, Eli Lilly and Company, New York, New York., Kalos M; Lilly Research Laboratories, Eli Lilly and Company, New York, New York.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2020 Apr; Vol. 19 (4), pp. 988-998.
Autor:
Li Y; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA. yiwen.li@lilly.com.; Eli Lilly and Company, 450 East 29th Street, New York, NY, 10016, USA. yiwen.li@lilly.com., Carpenito C; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Wang G; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Surguladze D; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Forest A; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Malabunga M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Murphy M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Zhang Y; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Sonyi A; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Chin D; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Burtrum D; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Inigo I; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Pennello A; Lilly Research Laboratories, Department of Preclinical Pharmacology, New York, NY, USA., Shen L; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Malherbe L; Lilly Research Laboratories, Department of Non-Clinical Safety, Indianapolis, IN, USA., Chen X; Lilly Research Laboratories, Department of Quantitative Biology, New York, NY, USA., Hall G; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Haidar JN; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Ludwig DL; Lilly Research Laboratories, Department of Biologics Technology, New York, NY, USA., Novosiadly RD; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA., Kalos M; Lilly Research Laboratories, Department of Cancer Immunobiology, New York, NY, USA. MKALOS@ITS.JNJ.COM.; Eli Lilly and Company, 450 East 29th Street, New York, NY, 10016, USA. MKALOS@ITS.JNJ.COM.; Janssen Pharmaceutical Companies of Johnson and Johnson, Springhouse, PA, USA. MKALOS@ITS.JNJ.COM.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Jun 04; Vol. 6 (1), pp. 45. Date of Electronic Publication: 2018 Jun 04.
Autor:
Li Y; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA yiwen.li@lilly.com.; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street 10016 New York NY USA., Carpenito C; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Wang G; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Surguladze D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Forest A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Malabunga M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Murphy M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Zhang Y; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Sonyi A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Chin D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Burtrum D; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Inigo I; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Pennello A; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Preclinical Pharmacology New York NY USA., Shen L; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Malherbe L; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Non-Clinical Safety Indianapolis IN USA., Chen X; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Quantitative Biology New York NY USA., Hall G; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Haidar JN; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Ludwig DL; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Biologics Technology New York NY USA., Novosiadly RD; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA., Kalos M; 0000 0000 2220 2544grid.417540.3Lilly Research Laboratories, Department of Cancer Immunobiology New York NY USA MKALOS@ITS.JNJ.COM.; 0000 0000 2220 2544grid.417540.3Eli Lilly and Company 450 East 29th Street 10016 New York NY USA.; grid.430674.2Janssen Pharmaceutical Companies of Johnson and Johnson Springhouse PA USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Apr 30; Vol. 6 (1), pp. 31. Date of Electronic Publication: 2018 Apr 30.
Autor:
Bagchi A; Graduate Group in Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Haidar JN; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Eastman SW; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Vieth M; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana., Topper M; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Iacolina MD; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Walker JM; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Forest A; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Shen Y; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Novosiadly RD; Lilly Research Laboratories, Eli Lilly & Company, New York, New York., Ferguson KM; Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. kathryn.ferguson@yale.edu.; Yale Cancer Biology Institute, West Haven, CT, and Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2018 Feb; Vol. 17 (2), pp. 521-531. Date of Electronic Publication: 2017 Nov 20.
Autor:
Maity H; Formulation Development, CMC Development, Eli Lilly and Company, 59-61 ImClone Drive, Branchburg, NJ 08876, USA. Electronic address: haripada.maity@lilly.com., Wei A; Formulation Development, CMC Development, Eli Lilly and Company, 59-61 ImClone Drive, Branchburg, NJ 08876, USA., Chen E; Formulation Development, CMC Development, Eli Lilly and Company, 59-61 ImClone Drive, Branchburg, NJ 08876, USA., Haidar JN; Antibody Technology Department, Alexandria Center for Life Sciences, Eli Lilly and Company, 450 East 29th Street, NY 10016, USA; Structural Biology Department, Alexandria Center for Life Sciences, Eli Lilly and Company, 450 East 29th Street, NY 10016, USA., Srivastava A; Formulation Development, CMC Development, Eli Lilly and Company, 59-61 ImClone Drive, Branchburg, NJ 08876, USA., Goldstein J; Formulation Development, CMC Development, Eli Lilly and Company, 59-61 ImClone Drive, Branchburg, NJ 08876, USA.
Publikováno v:
International journal of biological macromolecules [Int J Biol Macromol] 2015; Vol. 77, pp. 260-5. Date of Electronic Publication: 2015 Mar 25.
Autor:
Haidar JN; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA; Department of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, MA 02215, USA. Electronic address: jaafar.haidar@imclone.com., Zhu W; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Lypowy J; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Pierce BG; Bioinformatics Program, Boston University, 44 Cummington Street, Boston, MA 02215, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA., Bari A; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Persaud K; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Luna X; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Snavely M; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Ludwig D; ImClone Systems, a wholly subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, NY 10016, USA., Weng Z; Department of Biomedical Engineering, Boston University, 44 Cummington Street, Boston, MA 02215, USA; Bioinformatics Program, Boston University, 44 Cummington Street, Boston, MA 02215, USA; Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA. Electronic address: Zhiping.Weng@umassmed.edu.
Publikováno v:
Journal of molecular biology [J Mol Biol] 2014 Apr 03; Vol. 426 (7), pp. 1583-99. Date of Electronic Publication: 2013 Dec 28.
Autor:
Haidar JN; Department of Antibody Technology, ImClone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Alexandria Center for Life Sciences, New York, New York 10016, USA. jaafar.haidar@imclone.com, Yuan QA, Zeng L, Snavely M, Luna X, Zhang H, Zhu W, Ludwig DL, Zhu Z
Publikováno v:
Proteins [Proteins] 2012 Mar; Vol. 80 (3), pp. 896-912. Date of Electronic Publication: 2011 Dec 16.